MANI Stock Snapshot
1.21 B
Market Cap in USD
98.52 M
Number of Shares
35.00
Dividend in JPY
1.84
Dividend Yield
31.39
P/E Ratio
65.50
Free Float in %
60.45
EPS in JPY
505.87
Book Value per Share in JPY
81.57
Cash Flow per Share in JPY
MANI Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price |
---|
MANI Estimates* in JPY
2024 | 2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|---|
Revenue | 27,688 | 30,155 | - | 36,306 | 39,554 |
Dividend | 39.00 | 41.63 | 45.33 | 49.50 | 53.50 |
Dividend Yield (in %) | 1.98 % | 2.11 % | 2.30 % | 2.51 % | 2.71 % |
EPS | - | - | - | 83.45 | 91.50 |
P/E Ratio | 31.90 | 29.43 | 26.26 | 23.62 | 21.55 |
EBIT | 8,344 | - | - | 11,317 | 12,535 |
EBITDA | 10,480 | - | - | 14,317 | 15,685 |
Net Profit | - | - | - | 8,217 | 9,010 |
Net Profit Adjusted | - | - | - | - | - |
Pre-Tax Profit | 8,593 | - | - | 11,617 | 12,710 |
Net Profit (Adjusted) | 8,727 | - | - | 11,617 | 12,710 |
EPS (Non-GAAP) ex. SOE | - | - | - | - | - |
EPS (GAAP) | - | - | - | - | - |
Gross Income | 18,065 | 19,953 | 22,236 | 23,752 | 25,830 |
Cash Flow from Investing | -3,831 | -4,242 | -4,504 | -4,815 | -5,163 |
Cash Flow from Operations | 8,293 | 8,161 | 10,010 | 10,317 | 11,210 |
Cash Flow from Financing | -3,831 | -4,242 | -4,504 | -4,815 | -5,163 |
Cash Flow per Share | - | - | - | 110.00 | 120.00 |
Free Cash Flow | - | - | - | 7,417 | 8,210 |
Free Cash Flow per Share | 6.80 | 30.45 | 83.60 | 90.80 | 96.70 |
Book Value per Share | - | - | - | 649.95 | 696.90 |
Net Debt | -21,789 | -20,499 | -23,560 | -26,200 | -31,000 |
Research & Development Exp. | 2,350 | 2,600 | 2,800 | - | - |
Capital Expenditure | 7,792 | 5,262 | 3,962 | 3,600 | 3,700 |
Selling, General & Admin. Exp. | 9,265 | 10,210 | 11,424 | 12,435 | 13,295 |
Shareholder’s Equity | 52,777 | 55,710 | 59,132 | 64,000 | 68,600 |
Total Assets | 57,789 | 60,772 | 64,248 | 69,250 | 73,900 |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 08/31/24 |
Next Year ending 08/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | - | - | 2 | 2 |
Average Estimate | - | - | - | 83.450 JPY | 91.500 JPY |
Year Ago | - | - | - | - | - |
Publish Date | - | - | - | - | - |
Revenue Estimates | |||||
No. of Analysts | - | - | - | 8 | 8 |
Average Estimate | - | - | - | 27,688 JPY | 30,155 JPY |
Year Ago | - | - | - | 24,488 JPY | - |
Publish Date | - | - | - | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. JPY
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 24,488.00 | 20,416.00 | 17,190.00 | 15,200.18 | 18,327.30 | 20,102.76 | 17,167.55 |
Change of sales in % | 19.95 | 18.77 | 13.09 | -17.06 | -8.83 | 17.10 | 3.70 |
Gross profit on sales | 15,082.00 | 12,257.00 | 10,732.00 | 9,625.88 | 11,412.10 | 11,688.55 | 9,742.85 |
Gross profit on sales change in % | 23.05 | 14.21 | 11.49 | -15.65 | -2.37 | 19.97 | 2.45 |
Operating income | 7,245.00 | 6,158.00 | 5,327.00 | 4,340.93 | 5,865.18 | 5,080.26 | 4,261.37 |
Operating income change in % | 17.65 | 15.60 | 22.72 | -25.99 | 15.45 | 19.22 | 0.36 |
Income before tax | 8,018.00 | 7,419.00 | 6,001.00 | 4,831.74 | 8,399.11 | 5,188.93 | 4,646.32 |
Income before tax change in % | 8.07 | 23.63 | 24.20 | -42.47 | 61.87 | 11.68 | 14.63 |
Income after tax | 5,953.00 | 5,290.00 | 4,291.00 | 3,329.59 | 6,101.80 | 3,770.88 | 3,315.27 |
Income after tax change in % | 12.53 | 23.28 | 28.87 | -45.43 | 61.81 | 13.74 | 10.30 |
Balance Sheet in Mio. JPY
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 5,276.00 | 4,765.00 | 3,691.00 | 2,889.13 | 4,761.79 | 4,136.65 | 4,063.64 |
Long-term liabilities per share | 10.74 | 9.97 | 11.50 | 9.76 | 11.50 | 14.03 | 13.92 |
Equity | 49,827.00 | 45,414.00 | 39,202.00 | 36,566.73 | 35,327.14 | 33,546.84 | 30,478.48 |
Equity change in % | 9.72 | 15.85 | 7.21 | 3.51 | 5.31 | 10.07 | 13.80 |
Balance sheet total | 55,103.00 | 50,179.00 | 42,893.00 | 39,455.86 | 40,088.93 | 37,683.49 | 34,542.12 |
Balance sheet total change in % | 9.81 | 16.99 | 8.71 | -1.58 | 6.38 | 9.09 | 15.44 |
Key Data in JPY
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 248.68 | 207.42 | 174.65 | 154.43 | 186.20 | 204.24 | 174.42 |
P/E ratio (year end quote, basic EPS) | 31.39 | 32.67 | 49.94 | 79.46 | 40.05 | 42.24 | 25.22 |
P/E ratio (year end quote, diluted EPS) | 31.39 | 32.67 | 49.94 | 79.46 | 40.05 | 42.24 | 25.22 |
P/E ratio (year end quote) | 31.39 | 32.67 | 49.94 | 79.46 | 40.05 | 42.24 | 25.22 |
Dividend yield in % | 1.84 | 1.71 | 1.06 | 0.82 | 0.81 | 0.87 | 1.33 |
Equity ratio in % | 90.42 | 90.50 | 91.39 | 92.68 | 88.12 | 89.02 | 88.24 |
Debt ratio in % | 9.57 | 9.50 | 8.60 | 7.32 | 11.88 | 10.98 | 11.76 |
MANI Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | MANI INCShs | 35.00 | 1.84 | JPY |
2022 | MANI INCShs | 30.00 | 1.71 | JPY |
2021 | MANI INCShs | 23.00 | 1.06 | JPY |
2020 | MANI INCShs | 22.00 | 0.82 | JPY |
2019 | MANI INCShs | 20.00 | 0.81 | JPY |
2018 | MANI INCShs | 14.00 | 0.87 | JPY |
2017 | MANI INCShs | 11.33 | 1.33 | JPY |
2016 | MANI INCShs | 10.00 | 1.44 | JPY |
2015 | MANI INCShs | 8.89 | 0.98 | JPY |
2014 | MANI INCShs | 8.00 | 1.23 | JPY |
2013 | MANI INCShs | 6.89 | 1.89 | JPY |
2012 | MANI INCShs | 6.89 | 2.19 | JPY |
2011 | MANI INCShs | 6.67 | 2.24 | JPY |
2010 | MANI INCShs | 6.67 | 2.07 | JPY |
2009 | MANI INCShs | 5.00 | 1.43 | JPY |
*Yield of the Respective Date
MANI Profile
Mani, Inc. engages in the development, manufacture, and sale of medical instruments specializing in surgical and dental products. It operates through the following segments: Surgical-related Products, Eyeless-related Products, and Dental-related Products. The Surgical-related Products segment produces surgical medical devices, suturing tools, and ophthalmic knives. The Eyeless-related Products segment deals with the manufacture and distribution of suturing needles. The Dental-related Products segment manages the research and development, manufacture, and sale of dental instruments, root canal treatment devices, endodontic rotary cutting apparatus, and endodontic accessories. The company was founded by Masao Matsutani on May 1, 1956 and is headquartered in Utsunomiya, Japan. .
Moody’s Daily Credit Risk Score
MANI Shareholder
Owner | in % |
---|---|
Freefloat | 65.50 |
Matsutani Kanji Family | 9.91 |
Mani, Inc. | 7.93 |
Matsutani Family | 4.75 |
Sumitomo Mitsui Trust Asset Management Co., Ltd. | 4.19 |
Masamitsu Matsutani | 3.84 |
Mani Matsutani Medical Scholarship Foundation | 2.99 |
Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 2.19 |
Kanji Matsutani | 2.12 |
Threadneedle Asset Management Ltd. | 1.91 |
Masaaki Matsutani | 1.71 |
Government Pension Fund - Global (The) | 1.40 |
Sawakami Asset Sawakami Fund | 1.36 |
Kyoko Matsutani | 1.14 |
Nikko Asset Management Co., Ltd. | 1.11 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.